Down 30%, Is It Time To Buy This Pharma Giant?
Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So, is BMY a buy or a sell? » Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Read More2 Safe Stocks To Beat Inflation
In March, inflation surged by 8.5%, representing the highest increase since 1981. This four-decade high affects everything from energy to food costs. In a rising cost environment, where should you put your money?
Two stocks poised to beat inflation are: OneMain Holdings (NASDAQ: OMF) and Arbor Realty Trust (NASDAQ: ABR).
» Read more about: 2 Safe Stocks To Beat Inflation »
Read More3 Cathie Wood Stocks On Sale
» Read more about: 3 Cathie Wood Stocks On Sale »
Read MoreBillionaires Are Scooping Up These 4 Assets
The real estate industry has been on quite a journey over the last few years. After initially falling hard in the wake of the coronavirus and then quickly making a turn for the better, real estate prices have continued to soar to new heights since 2020. That’s just the housing market, though. What about the other assets that make up the real estate industry?
» Read more about: Billionaires Are Scooping Up These 4 Assets »
Read MoreMarket Commentary: 1 Food Stock That Defies All Odds
Famously, it’s been said that the restaurant business is a horrible one. You have to pay the rent, the staff, the food costs, and keep the lights on, and when you’re done with all that you have to hope your menu is right, the chefs show up each day, and the customers like the food.
» Read more about: Market Commentary: 1 Food Stock That Defies All Odds »
Read MoreThe Burst
Alert: 38% Upside In Super Boring Stock
Investment Alert: Buy Oracle (ORCL) Under $120
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Larry Ellison ranks among the richest men in the world thanks to the roaring success of the company he founded in 1977,
» Read more about: Alert: 38% Upside In Super Boring Stock »
Read MoreThe Spotlight
80% Of Physicians Use This Platform, Is It a Buy?
2021 was an epic year for IPOs, primarily driven by very low interest rates, and COVID-19 stimulus funding. In fact, in 2021, there were 976 IPOs, compared to 480 the prior year. One of the most noteworthy IPOs of the year was Doximity, Inc. (DOCS), which opened at $26 per share.
» Read more about: 80% Of Physicians Use This Platform, Is It a Buy? »
Read MoreThe Daily
Biblical ETF Firm Misrepresented Its Investing Strategy: SEC
Inspire also lacked written policies and procedures setting forth a process for evaluating companies’ activities as part of its investment process, which at times resulted in inconsistent application of its investment criteria.
As a result, Inspire Investing “invested in companies engaged in activities that did not align with Inspire Investing’s own stated criteria and in which the advisory firm represented that it would not invest.”
“Investors must be able to rely on advisers acting consistently with their represented investment process or strategy,” said Corey Schuster,
» Read more about: Biblical ETF Firm Misrepresented Its Investing Strategy: SEC »